MCAT · Organ Systems and Homeostasis

Lymphatic and Immune Systems (3B)

How the body's surveillance network defends against pathogens and maintains fluid homeostasis.

MCAT emblem with a laboratory flask, DNA, and a brain.
Inside this lesson 10 sections 5 questions 5 figures

SECTION 1

Historical Context & Motivation

The history of immunology is one of the most intellectually rich narratives in biomedical science, weaving together clinical observation, microbiology, and molecular biology over several centuries. Long before the germ theory of disease was formalized, physicians recognized that survivors of certain plagues rarely fell ill a second time—an empirical observation that hinted at the existence of immunological memory. The lymphatic system itself was identified anatomically before its immunological significance was appreciated, initially understood merely as a conduit for fluid return. It was only through the convergence of cellular pathology, bacteriology, and biochemistry in the late 19th and 20th centuries that the lymphatic and immune systems were recognized as an integrated defense apparatus critical to homeostasis.

1796 • Jenner's Vaccination

Edward Jenner demonstrated that inoculation with cowpox material conferred protection against smallpox, establishing the principle of vaccination and providing the first deliberate manipulation of adaptive immunity.

1882 • Metchnikoff and Phagocytosis

Élie Metchnikoff observed mobile cells in starfish larvae engulfing foreign particles, coining the term phagocytosis and founding the cellular theory of immunity, which emphasized the role of innate immune cells.

1890 • von Behring and Antitoxins

Emil von Behring and Shibasaburo Kitasato demonstrated that serum from immunized animals contained antitoxins (antibodies) capable of neutralizing diphtheria toxin, establishing the humoral theory of immunity.

1957 • Clonal Selection Theory

Frank Macfarlane Burnet proposed the clonal selection theory, positing that antigen selects pre-existing lymphocyte clones bearing complementary receptors, triggering their proliferation and differentiation.

1987 • Tonegawa and V(D)J Recombination

Susumu Tonegawa received the Nobel Prize for elucidating V(D)J recombination, the somatic gene rearrangement mechanism that generates the vast diversity of antibody and T-cell receptor specificities from a limited germline genome.

The central question that drove immunological research—and remains essential for the MCAT—is deceptively simple: how does the body distinguish self from non-self, mount a proportionate defensive response, and remember prior encounters so that subsequent exposures elicit faster, stronger reactions? Understanding the lymphatic and immune systems requires integrating anatomy, cell biology, molecular signaling, and genetics into a coherent framework of host defense and homeostatic regulation.

SECTION 2

Core Principles & Definitions

The lymphatic system and immune system are functionally intertwined: the lymphatic vasculature provides the anatomical infrastructure through which immune cells circulate, encounter antigens, and coordinate responses. The lymphatic system consists of a network of lymphatic capillaries, collecting vessels, lymph nodes, and lymphoid organs (thymus, spleen, tonsils, Peyer's patches) that collectively drain interstitial fluid—now termed lymph—back into the venous circulation. This drainage function is essential for maintaining fluid balance and preventing edema, but it also serves as a surveillance conduit, funneling antigens and antigen-presenting cells toward lymph nodes where adaptive immune responses are initiated.

1

Innate Immunity

The rapid, non-specific first line of defense comprising physical barriers (skin, mucosa), chemical barriers (lysozyme, defensins, low pH), and cellular components (neutrophils, macrophages, NK cells, dendritic cells). Innate immunity is germline-encoded and does not improve with repeated exposure.
2

Adaptive Immunity

The antigen-specific, slower-onset arm mediated by T lymphocytes and B lymphocytes. Hallmarks include specificity, diversity, memory, and self/non-self discrimination. Receptor diversity arises via somatic V(D)J recombination.
3

Humoral vs. Cell-Mediated

Adaptive immunity bifurcates into humoral immunity (antibody-mediated, effective against extracellular pathogens) and cell-mediated immunity (T-cell-mediated, targeting intracellular pathogens and abnormal cells).
4

Active vs. Passive Immunity

Active immunity results from exposure to antigen (natural infection or vaccination) and generates memory cells. Passive immunity involves transfer of preformed antibodies (maternal IgG across placenta, therapeutic antiserum) and provides immediate but temporary protection.
5

Lymphatic Fluid Dynamics

Approximately 3 liters of fluid per day escape capillary beds due to Starling forces and are recovered by lymphatic capillaries. Lymph flows unidirectionally via skeletal muscle contraction, respiratory movements, and one-way valves, ultimately draining into the subclavian veins.
✦

KEY TAKEAWAY

Think of the immune system as a layered security architecture analogous to a research institution's cybersecurity framework. The innate immune system functions like a firewall—always on, broadly filtering threats based on conserved signatures (PAMPs). The adaptive immune system is the specialized threat-analysis team: it takes longer to mobilize, identifies threats with exquisite specificity, and maintains a database of prior encounters (immunological memory) so that repeat intrusions are neutralized faster. The lymphatic vasculature serves as the internal communication network connecting surveillance nodes (lymph nodes) throughout the body.

SECTION 3

Visual Explanation — Lymphatic System Architecture

Lymphatic System — Fluid Recovery & Immune SurveillanceBlood Capillary BedArterial endVenous endFiltration → ~20 L/day out; ~17 L reabsorbedInterstitial Space (~3 L excess/day)Lymph entersLymphatic CapillaryLymph Node(APC + T/B cells)Thoracic DuctReturns to venous bloodLymphoid OrgansThymus (Primary)T-cell maturation & selectionBone Marrow (Primary)B-cell maturation; all hematopoiesisSpleen (Secondary)Filters blood; RBC recyclingMALT / Peyer's PatchesMucosal immune surveillanceLymph Nodes (Secondary)Antigen presentation; clonal expansionPrimary organs: site of lymphocyte developmentSecondary organs: site of immune activation
Overview of the lymphatic system showing fluid recovery from the interstitial space through lymphatic capillaries and lymph nodes, draining via the thoracic duct back into venous circulation. Primary lymphoid organs (thymus, bone marrow) are sites of lymphocyte development, while secondary organs (spleen, lymph nodes, MALT) are sites of antigen encounter and immune activation.

As depicted in the diagram, approximately 20 liters of fluid per day are filtered from blood capillary beds into the interstitial space, driven by hydrostatic pressure exceeding oncotic pressure at the arterial end (Starling forces). About 17 liters are reabsorbed at the venous end where oncotic pressure predominates, leaving roughly 3 liters that must be recovered by lymphatic capillaries. These thin-walled, blind-ended vessels possess overlapping endothelial flaps that function as one-way microvalves, allowing interstitial fluid and macromolecules—including antigens and dendritic cells carrying processed antigen—to enter the lymphatic system. From lymphatic capillaries, lymph flows through progressively larger collecting vessels equipped with smooth muscle and one-way valves, passing through chains of lymph nodes where it is filtered and surveyed by resident macrophages, dendritic cells, and lymphocytes. Ultimately, the majority of lymph drains into the thoracic duct and returns to the blood at the junction of the left internal jugular and left subclavian veins. The right lymphatic duct handles drainage from the right upper quadrant of the body.

SECTION 4

Immune Response Mechanisms — Innate and Adaptive

Innate Immune Mechanisms

The innate immune response is initiated within minutes of pathogen entry and relies on germline-encoded pattern recognition receptors (PRRs) that detect conserved molecular motifs known as pathogen-associated molecular patterns (PAMPs). The most extensively characterized family of PRRs are the Toll-like receptors (TLRs), which include TLR4 (recognizing lipopolysaccharide from Gram-negative bacteria), TLR3 (double-stranded RNA from viruses), and TLR9 (unmethylated CpG DNA motifs). Engagement of TLRs activates NF-κB and interferon regulatory factor (IRF) signaling cascades, leading to transcription of pro-inflammatory cytokines (TNF-α, IL-1, IL-6), type I interferons (IFN-α, IFN-β), and chemokines that recruit additional immune cells to the site of infection.

The complement system constitutes a major humoral arm of innate immunity. It can be activated through three pathways: the classical pathway (antibody-antigen complexes activating C1), the lectin pathway (mannose-binding lectin on microbial surfaces), and the alternative pathway (spontaneous C3 hydrolysis amplified on pathogen surfaces). All three converge at the formation of C3 convertase, which cleaves C3 into C3a (anaphylatoxin) and C3b (opsonin). Downstream, C5 convertase generates C5a (potent chemoattractant) and C5b, which nucleates assembly of the membrane attack complex (MAC, C5b–C9) that lyses Gram-negative bacteria by forming transmembrane pores.

Adaptive Immune Mechanisms

Adaptive immunity is initiated when antigen-presenting cells (APCs)—primarily dendritic cells—process pathogen-derived peptides and display them on major histocompatibility complex (MHC) molecules. MHC class I molecules are expressed on all nucleated cells and present endogenous peptides (8–10 amino acids) to CD8⁺ cytotoxic T lymphocytes (CTLs). MHC class II molecules are expressed on professional APCs (dendritic cells, macrophages, B cells) and present exogenous peptides (13–25 amino acids) to CD4⁺ helper T cells (TH cells). This distinction is critical: MHC I → CD8⁺; MHC II → CD4⁺.

T-cell activation requires two signals: (1) TCR recognition of peptide–MHC complex and (2) co-stimulation via CD28 on the T cell engaging B7 (CD80/CD86) on the APC. Without co-stimulation, the T cell becomes anergic (functionally unresponsive), a mechanism of peripheral tolerance that prevents autoimmunity. Activated CD4⁺ TH cells differentiate into subsets: TH1 (activates macrophages via IFN-γ; promotes cell-mediated immunity), TH2 (drives B-cell class switching via IL-4, IL-5; promotes humoral immunity), TH17 (recruits neutrophils via IL-17; important in mucosal defense), and Treg cells (suppress immune responses; maintain tolerance).

💡

MCAT High-Yield

B-cell activation and class switching: Naïve B cells initially express IgM and IgD. Upon antigen binding and TH cell help (CD40L–CD40 interaction + cytokines), B cells undergo class switching (isotype switching), changing the constant region of the heavy chain without altering antigen specificity. Somatic hypermutation introduces point mutations in variable regions, and subsequent selection for higher-affinity clones constitutes affinity maturation.

SECTION 5

Immune Cell Classification & Antibody Isotypes

Immune Cell Lineage & Key FunctionsHematopoietic Stem CellMyeloid ProgenitorLymphoid ProgenitorNeutrophilPhagocytosisMacrophageAPC + PhagocyteDendritic CellBest APCMast CellHistamineT CellMatures: ThymusB CellMatures: MarrowNK CellInnate cytotoxicityCD4⁺ T HelperMHC II restrictedCD8⁺ CytotoxicMHC I restrictedTH1 (IFN-γ)TH2 (IL-4/5)TH17 (IL-17)Plasma CellSecretes AntibodiesOrange = Myeloid lineage (innate) | Cyan/Violet = Lymphoid lineage (adaptive) | Pink = NK (innate lymphoid)All cells arise from a common hematopoietic stem cell in the bone marrow
Hematopoietic lineage diagram showing divergence of myeloid progenitors (giving rise to innate immune cells) and lymphoid progenitors (giving rise to T cells, B cells, and NK cells). CD4⁺ T cells differentiate into functional subsets (TH1, TH2, TH17), while B cells differentiate into antibody-secreting plasma cells.

Antibody Isotypes

IsotypeStructureLocation & FunctionMCAT Focus
IgGMonomer; most abundant serum IgOpsonization, complement activation (classical), neonatal immunity; crosses placentaOnly Ig to cross placenta (passive immunity to fetus)
IgADimer (secretory form) with J chain + secretory componentMucosal surfaces (GI, respiratory, urogenital), breast milk, saliva, tearsMost produced Ig overall; prevents pathogen attachment at mucosa
IgMPentamer (secreted); monomer on B-cell surfaceFirst antibody in primary response; potent complement activator (10 binding sites)Indicates acute/recent infection; does NOT cross placenta
IgEMonomer; lowest serum concentrationBound to mast cells/basophils via Fc receptors; mediates type I hypersensitivity (allergy) and anti-parasitic defenseAllergic reactions; helminth defense; triggers histamine release
IgDMonomer; surface-boundCo-expressed with IgM on naïve B cells; functions as B-cell receptor (BCR)Role in B-cell activation; exact function still under investigation

The five immunoglobulin isotypes and their key properties for MCAT review.

A useful mnemonic for remembering antibody isotype order of production during a primary immune response is that IgM is produced first ("M" for "iMMediate"), followed by class switching to IgG (the dominant isotype during secondary responses due to memory B cells). The switch from IgM to IgG during the primary-to-secondary response transition is accompanied by increased antibody affinity through somatic hypermutation in germinal centers—a process termed affinity maturation.

SECTION 6

Worked Example — Tracing an Immune Response

Consider the following MCAT-style scenario: A patient steps on a rusty nail contaminated with Staphylococcus aureus. Trace the sequential immune responses from initial barrier breach through resolution, identifying the key cells, molecules, and processes at each stage.

Immune Response to S. aureus Wound Infection

  1. 1

    Step 1 — Barrier Breach and Innate Recognition

    The nail penetrates the epidermis and dermis, disrupting the skin barrier (the body's first line of defense). S. aureus enters the subcutaneous tissue. Resident macrophages and mast cells in the dermis detect bacterial PAMPs: peptidoglycan and lipoteichoic acid are recognized by TLR2; flagellin by TLR5. Mast cells degranulate, releasing histamine and other vasoactive mediators.
    Innate PRR activation → Inflammatory mediator release
  2. 2

    Step 2 — Acute Inflammation and Neutrophil Recruitment

    Histamine and prostaglandins cause local vasodilation and increased vascular permeability, producing the cardinal signs of inflammation: rubor (redness), calor (heat), tumor (swelling), and dolor (pain). Activated macrophages secrete TNF-α, IL-1, and IL-8 (a CXC chemokine). TNF-α and IL-1 upregulate selectins (E-selectin, P-selectin) and integrins (ICAM-1) on vascular endothelium. Circulating neutrophils undergo margination, rolling, adhesion, and diapedesis (extravasation) into the infected tissue, guided by the IL-8 chemokine gradient.
    Neutrophil infiltration via selectin/integrin-mediated adhesion cascade
  3. 3

    Step 3 — Phagocytosis and Complement Activation

    Neutrophils and macrophages phagocytose opsonized bacteria. Opsonins include C3b (from alternative complement pathway activation on the bacterial surface) and, later, IgG antibodies if the patient has prior immunity. Phagocytosed bacteria are killed within the phagolysosome by reactive oxygen species (respiratory burst: NADPH oxidase → O₂⁻ → H₂O₂ → HOCl via myeloperoxidase) and lysosomal enzymes. Simultaneously, the complement cascade proceeds to generate C3a and C5a (anaphylatoxins promoting further inflammation) and potentially the MAC.
    Opsonization + Respiratory burst → Bacterial killing
  4. 4

    Step 4 — Adaptive Immune Activation

    Dendritic cells in the tissue internalize bacterial antigens, process them through the exogenous (endosomal) pathway, and load peptide fragments onto MHC class II molecules. These activated DCs migrate via afferent lymphatics to the draining regional lymph node, where they present antigen to naïve CD4⁺ T cells in the paracortex. A naïve T cell whose TCR is complementary to the peptide–MHC II complex, receiving both signal 1 (TCR engagement) and signal 2 (B7–CD28 co-stimulation), undergoes clonal expansion. IL-12 from the DC drives TH1 differentiation. Meanwhile, B cells in the lymph node cortex that recognize bacterial surface antigens via their BCR internalize and process antigen, presenting it on MHC II to cognate TH cells (linked recognition). CD40L–CD40 interaction + TH cytokines drive B-cell proliferation, class switching (IgM → IgG), somatic hypermutation, and differentiation into plasma cells and memory B cells.
    Clonal expansion of antigen-specific T and B cells in lymph node
  5. 5

    Step 5 — Effector Phase and Resolution

    IgG antibodies reach the infection site via blood, opsonizing bacteria and enhancing phagocytosis (Fc receptor-mediated). TH1 cells secrete IFN-γ, activating macrophages to a heightened microbicidal state. As bacterial load decreases, pro-inflammatory signals wane and anti-inflammatory cytokines (IL-10, TGF-β) promote resolution. Apoptosis of excess effector lymphocytes occurs (contraction phase), but a subset of long-lived memory T cells and memory B cells persist, enabling a faster, more robust secondary response upon re-exposure.
    Infection cleared; immunological memory established

SECTION 7

Innate vs. Adaptive Immunity — Comparative Analysis

FeatureInnate ImmunityAdaptive Immunity
SpecificityBroad; recognizes conserved PAMPsHighly specific; recognizes unique epitopes
ReceptorsPRRs (TLRs, NLRs, RLRs); germline-encodedTCRs, BCRs/antibodies; somatically rearranged
Speed of ResponseMinutes to hoursDays (primary); hours (secondary/memory)
MemoryNo classical memory (some trained immunity in monocytes)Robust memory via memory T and B cells
Key CellsNeutrophils, macrophages, DCs, NK cells, mast cells, eosinophils, basophilsCD4⁺ T cells, CD8⁺ T cells, B cells, plasma cells
Soluble MediatorsComplement, cytokines (TNF-α, IL-1, IL-6), interferons, defensinsAntibodies, cytokines (IL-2, IL-4, IL-5, IFN-γ, IL-17)
DiversityLimited (~10² distinct PRRs)Immense (~10⁹–10¹¹ distinct specificities via V(D)J recombination)

Comparative features of innate and adaptive immunity.

✦

KEY TAKEAWAY

The innate and adaptive systems do not operate in isolation; they are functionally integrated through a concept known as the innate-adaptive bridge. Dendritic cells are the pivotal link: they use innate PRRs to detect pathogens, then migrate to lymph nodes and activate adaptive lymphocytes via antigen presentation and co-stimulation. Similarly, antibodies produced by the adaptive system (IgG, IgM) enhance innate mechanisms through opsonization and classical complement activation. This bidirectional cross-talk ensures that the speed of innate immunity and the precision of adaptive immunity are coordinated for optimal host defense.

SECTION 8

Clinical Connections — Tolerance, Hypersensitivity, and Immunodeficiency

The MCAT frequently tests the consequences of immune dysregulation, which can be broadly categorized into three domains: loss of tolerance (autoimmunity), excessive or misdirected responses (hypersensitivity), and insufficient immune function (immunodeficiency). Mastering these clinical correlates requires understanding the normal physiological mechanisms that prevent such pathology.

Tolerance Mechanisms

Central tolerance occurs during lymphocyte development. In the thymus, developing T cells (thymocytes) that bind self-peptide–MHC complexes with high affinity undergo negative selection (clonal deletion via apoptosis). The AIRE (autoimmune regulator) gene drives expression of tissue-specific antigens in the thymic medulla, enabling deletion of self-reactive T cells. In the bone marrow, self-reactive B cells undergo receptor editing (rearranging light chain genes to change specificity) or clonal deletion. Peripheral tolerance mechanisms handle self-reactive lymphocytes that escape central deletion: anergy (functional unresponsiveness without co-stimulation), suppression by Treg cells (via IL-10, TGF-β, CTLA-4), and activation-induced cell death (AICD via Fas–FasL interaction).

Hypersensitivity TypeMechanismTimingExamples
Type I (Immediate)IgE-mediated mast cell/basophil degranulationMinutesAnaphylaxis, allergic rhinitis, asthma, food allergy
Type II (Cytotoxic)IgG/IgM bind cell-surface antigens → complement/ADCC/phagocytosisHoursHemolytic disease of the newborn, autoimmune hemolytic anemia, Graves' disease
Type III (Immune complex)Antigen–antibody complexes deposit in tissues → complement activationHours–daysSerum sickness, SLE (lupus nephritis), Arthus reaction
Type IV (Delayed)T-cell mediated (CD4⁺ T cells + macrophages); no antibody involvement24–72 hoursContact dermatitis (poison ivy), tuberculin (PPD) test, transplant rejection

Gell and Coombs classification of hypersensitivity reactions.

⚠

Immunodeficiency — Key Distinctions

Primary (congenital) immunodeficiencies result from genetic defects: X-linked agammaglobulinemia (Bruton's; BTK mutation → no mature B cells → absent antibodies), DiGeorge syndrome (thymic aplasia → T-cell deficiency), SCID (absent both T and B cell function). Secondary (acquired) immunodeficiencies are more common and include HIV/AIDS (CD4⁺ T-cell depletion), immunosuppressive therapy, malnutrition, and chronic stress. For the MCAT, correlate the type of deficiency with the predicted infection profile: B-cell/antibody defects → recurrent encapsulated bacterial infections (S. pneumoniae, H. influenzae); T-cell defects → opportunistic infections (fungi, viruses, intracellular bacteria).

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A researcher observes that a patient's lymph nodes are significantly enlarged (lymphadenopathy) following a viral respiratory infection. Explain the immunological basis for this observation, specifying which cell populations expand and in which anatomical compartments of the lymph node.
Show answer
Lymphadenopathy during a viral infection reflects active immune activation within the lymph node. Dendritic cells carrying viral antigens migrate from the respiratory mucosa via afferent lymphatics and present processed peptides on MHC class I and MHC class II molecules to T cells in the paracortex (T-cell zone). Antigen-specific CD4⁺ and CD8⁺ T cells undergo clonal expansion, causing paracortical swelling. Simultaneously, B cells in the cortical follicles that recognize viral surface antigens receive T-cell help and form germinal centers, where they undergo somatic hypermutation, affinity maturation, and class switching. The combined proliferation of T and B lymphocytes, along with increased lymph flow carrying antigen, accounts for the palpable enlargement of the node.

Question 2: BASIC CALCULATION

If a human has approximately 10⁹ distinct B-cell receptor specificities generated through V(D)J recombination, and the heavy chain locus contains 40 functional VH segments, 25 DH segments, and 6 JH segments, while the kappa light chain locus has 40 Vκ segments and 5 Jκ segments, calculate the combinatorial diversity from V(D)J recombination alone (ignoring junctional diversity, somatic hypermutation, and heavy-light chain pairing).
Show answer
For the heavy chain, combinatorial diversity = VH × DH × JH = 40 × 25 × 6 = 6,000 possible heavy chains. For the kappa light chain, combinatorial diversity = Vκ × Jκ = 40 × 5 = 200 possible light chains. Combining heavy and light chain pairing yields 6,000 × 200 = 1.2 × 10⁶ specificities from combinatorial diversity alone. The remaining orders of magnitude to reach ~10⁹–10¹¹ total diversity come from junctional diversity (P-nucleotide and N-nucleotide addition at coding joints by TdT) and somatic hypermutation during the germinal center reaction.

Question 3: INTERMEDIATE

A patient presents with recurrent infections by encapsulated bacteria (Streptococcus pneumoniae, Haemophilus influenzae) beginning at 6 months of age. Serum analysis reveals undetectable immunoglobulin levels and absent B cells in peripheral blood, though T-cell counts and function are normal. Which immunodeficiency is most consistent with this presentation, what is the molecular defect, and why does symptom onset coincide with 6 months of age?
Show answer
This presentation is classic for X-linked agammaglobulinemia (Bruton's agammaglobulinemia), caused by a mutation in the BTK (Bruton's tyrosine kinase) gene on the X chromosome. BTK is essential for pre-B cell receptor signaling during B-cell maturation in the bone marrow; its absence blocks B-cell development at the pre-B cell stage, resulting in absent mature B cells and consequently no immunoglobulin production. The onset at ~6 months is explained by the decline of maternal IgG transferred across the placenta during the third trimester. This passively acquired IgG has a half-life of approximately 21 days and is largely catabolized by 6 months, leaving the infant unprotected. Encapsulated organisms are particularly problematic because their polysaccharide capsules resist phagocytosis unless opsonized by antibodies—precisely the effector arm these patients lack.

Question 4: APPLIED

An immunology researcher is designing a subunit vaccine against a novel intracellular pathogen. The vaccine contains a recombinant surface protein of the pathogen combined with an adjuvant. Predict the expected primary and secondary immune responses, and explain why the vaccine might be less effective against intracellular pathogens compared to extracellular ones. What modifications could enhance efficacy?
Show answer
A subunit vaccine containing a recombinant surface protein will primarily stimulate the humoral (antibody-mediated) arm of adaptive immunity. During the primary response, dendritic cells will process the exogenous protein through the endosomal pathway, load peptides onto MHC class II, and activate CD4⁺ TH cells. These will help B cells undergo class switching and differentiation into plasma cells secreting IgG, along with memory B-cell generation. Upon re-exposure (secondary response), memory cells mount a faster, higher-titer IgG response with greater affinity. However, against an intracellular pathogen, antibodies have limited efficacy because the pathogen resides within host cells, inaccessible to circulating immunoglobulins. Effective clearance requires cell-mediated immunity—specifically, CD8⁺ CTLs that recognize infected cells via MHC class I presentation. To enhance efficacy, the researcher could: (1) use adjuvants that promote cross-presentation (enabling exogenous antigens to access the MHC I pathway), (2) employ DNA or mRNA vaccines that direct host cells to synthesize the antigen endogenously, ensuring MHC I presentation, or (3) incorporate TH1-skewing adjuvants (e.g., TLR agonists) that favor IFN-γ production and CTL activation.

Question 5: CRITICAL THINKING

CTLA-4 and PD-1 are both inhibitory receptors expressed on T cells, yet their blockade (checkpoint immunotherapy) has revolutionized cancer treatment. Compare and contrast the mechanisms by which CTLA-4 and PD-1 suppress T-cell activation, explain why their blockade enhances anti-tumor immunity, and predict potential adverse effects of such therapy based on your understanding of immune tolerance.
Show answer
CTLA-4 (CD152) is a homolog of CD28 that binds B7 (CD80/CD86) on APCs with ~20-fold higher affinity. It functions primarily during the priming phase of T-cell activation in the lymph node by competitively outbinding CD28, preventing co-stimulatory signal 2 and thereby attenuating T-cell activation. CTLA-4 also transduces intrinsic inhibitory signals and can physically strip B7 from APC surfaces (trans-endocytosis). PD-1 (CD279) binds PD-L1/PD-L2 on tumor cells and APCs, primarily functioning in the effector phase at the tumor microenvironment to induce T-cell exhaustion—a state of reduced proliferation, cytokine production, and cytolytic function. PD-1 signaling recruits phosphatase SHP-2, which dephosphorylates key TCR signaling intermediates. Blocking CTLA-4 (e.g., ipilimumab) releases the brakes during T-cell priming, broadly amplifying T-cell activation. Blocking PD-1/PD-L1 (e.g., nivolumab, pembrolizumab) reinvigorates exhausted tumor-infiltrating lymphocytes. Because both pathways normally participate in peripheral tolerance, their blockade predictably causes immune-related adverse events (irAEs) resembling autoimmune diseases: colitis, hepatitis, pneumonitis, thyroiditis, and dermatitis. Anti-CTLA-4 therapy, with its broader mechanism of action, tends to produce more frequent and severe irAEs than anti-PD-1 therapy.

SUMMARY

Lesson Summary

Summary

The lymphatic system recovers approximately 3 L/day of interstitial fluid and serves as the anatomical highway for immune cell trafficking through lymph nodes, where antigen encounter and adaptive immune activation occur. Innate immunity provides rapid, non-specific defense through barriers, phagocytes (neutrophils, macrophages), NK cells, and the complement system (classical, lectin, and alternative pathways converging at C3 convertase). Pattern recognition receptors (TLRs) detect PAMPs and activate NF-κB-driven inflammatory cascades.

Adaptive immunity is mediated by T and B lymphocytes possessing somatically rearranged receptors generated via V(D)J recombination. MHC class I presents endogenous peptides to CD8⁺ CTLs; MHC class II presents exogenous peptides to CD4⁺ T helper cells. B-cell activation requires T-cell help (CD40L–CD40 + cytokines), driving class switching, somatic hypermutation, and affinity maturation. Five antibody isotypes (IgG, IgA, IgM, IgE, IgD) serve distinct effector functions. Tolerance mechanisms (central and peripheral) prevent autoimmunity, while their failure manifests as hypersensitivity reactions (Types I–IV) or autoimmune disease. Immunodeficiencies—primary (Bruton's, DiGeorge, SCID) or secondary (HIV)—reveal the critical role of each immune component when absent.

Varsity Tutors • MCAT Biological & Biochemical Foundations of Living Systems • Lymphatic and Immune Systems (3B)